We are live on ! Find out more
TCRT icon

Alaunos Therapeutics
TCRT

70 hedge funds and large institutions have $83.2M invested in Alaunos Therapeutics in 2013 Q2 according to their latest regulatory filings, with 70 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

76% more call options, than puts

Call options by funds: $3.04M | Put options by funds: $1.72M

Holders
70
Holders Change
+70
Holders Change %
–
% of All Funds
2.28%
Holding in Top 10
2
Holding in Top 10 Change
+2
Holding in Top 10 Change %
% of All Funds
0.07%
New
70
Increased
–
Reduced
–
Closed
–
Calls
$3.04M
Puts
$1.72M
Net Calls
+$1.31M
Net Calls Change
+$1.31M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
TS
1
Third Security
Virginia
$31.5M +$27.7M +99,598 New
Fidelity Investments
2
Fidelity Investments
Massachusetts
$13.4M +$11.9M +42,699 New
EWM
3
Essex Woodlands Management
Texas
$5.41M +$5.12M +18,433 New
Vanguard Group
4
Vanguard Group
Pennsylvania
$3.85M +$3.39M +12,209 New
BFA
5
BlackRock Fund Advisors
California
$3.53M +$3.09M +11,142 New
MP
6
MSD Partners
New York
$2.43M +$2.13M +7,667 New
State Street
7
State Street
Massachusetts
$2.25M +$1.98M +7,137 New
Northern Trust
8
Northern Trust
Illinois
$1.99M +$1.75M +6,300 New
BIT
9
BlackRock Institutional Trust
California
$1.9M +$1.67M +6,008 New
SCA
10
SAC Capital Advisors
Connecticut
$1.86M +$1.64M +5,920 New
RA
11
Royce & Associates
New York
$1.39M +$1.22M +4,400 New
Susquehanna International Group
12
Susquehanna International Group
Pennsylvania
$1.31M +$1.16M +4,177 New
Barclays
13
Barclays
United Kingdom
$1.25M +$1.09M +3,940 New
Morgan Stanley
14
Morgan Stanley
New York
$1.15M +$1.01M +3,622 New
Bank of New York Mellon
15
Bank of New York Mellon
New York
$787K +$690K +2,484 New
Geode Capital Management
16
Geode Capital Management
Massachusetts
$697K +$614K +2,211 New
TCIM
17
TIAA CREF Investment Management
New York
$637K +$562K +2,023 New
CB
18
Commerce Bank
Missouri
$633K +$555K +2,000 New
BBA
19
Baker Bros. Advisors
New York
$536K +$471K +1,695 New
Group One Trading
20
Group One Trading
Illinois
$499K +$440K +1,584 New
Goldman Sachs
21
Goldman Sachs
New York
$390K +$342K +1,232 New
Janus Henderson Group
22
Janus Henderson Group
United Kingdom
$389K +$342K +1,233 New
BIM
23
BlackRock Investment Management
Delaware
$384K +$337K +1,213 New
Charles Schwab
24
Charles Schwab
California
$357K +$312K +1,125 New
ACI
25
AMP Capital Investors
Australia
$288K +$232K +834 New
1
2 3

TCRT Hedge Fund Activity: Q2 2013 in Review

70 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Alaunos Therapeutics (TCRT) for Q2 2013, worth a combined $83.2M.

Buyers outnumbered sellers: 70 funds opened new TCRT positions and 0 closed out — a net gain of 70 holders — while 0 added to existing stakes and 0 trimmed.

  • 70 institutional investors held Alaunos Therapeutics (TCRT) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $83.2M of Alaunos Therapeutics stock for Q2 2013.
  • 70 funds opened new Alaunos Therapeutics positions in Q2 2013 and 0 closed out, a net change of +70 holders.

Based on aggregated 13F filings for Q2 2013.